Products Categories
| CAS No.: | 70161-10-3 |
|---|---|
| Name: | 5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]salicylamide monohydrochloride |
| Article Data: | 3 |
| Molecular Structure: | |
|
|
|
| Formula: | C20H24N2O5•ClH |
| Molecular Weight: | 408.882 |
| Synonyms: | Medroxalol HCl;EINECS 274-347-3;5-[1-hydroxy-2-[4-(3,4-methylenedioxyphenyl)-2-butylamino]ethyl]salicylamide hydrochloride;5-(2-((3-(1,3-Benzodioxol-5-yl)-1-methylpropyl)amino)-1-hydroxyethyl)salicylamide monohydrochloride;Medroxalol hydrochloride [USAN];Benzamide,5-(2-((3-(1,3-benzodioxol-5-yl)-1-methylpropyl)amino)-1-hydroxyethyl)-2-hydroxy-,monohydrochloride;Medroxalol hydrochloride;5-(2-((3-(1,3-Benzodioxol-5-yl)-1-methylpropyl)amino)-1-hydroxyethyl)-2-hydroxybenzamide HCl; |
| Density: | g/cm3 |
| Boiling Point: | 604.1°Cat760mmHg |
| Flash Point: | 319.1°C |
| Safety: | Questionable carcinogen with experimental neoplastigenic data reported. When heated to decomposition it emits toxic vapors of NOx and HCl. |
| PSA: | 114.04000 |
| LogP: | 2.95530 |
- 81281-59-67-Benzylideneaminotheophylline
- 82993-81-5D-threo-Ritalinic acid hydrochloride
- 73441-42-6METHYL-5-CHLORO-2,2-DIMETHYLVALERATE
- 852475-26-4MC1568
- 958254-66-51H-Imidazo[4,5-b]pyridine-2-carboxaldehyde, 1-methyl-, hydrochloride
- 99170-93-1N-Methyl-2-oxazolamine
- 717878-06-31-(4-fluorophenyl)-4-nitro-1H-imidazole
- 914458-26-7[5-(2-fluorophenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naphthalenyl-Methanone
- 894852-01-87-BROMO-2,2-DIMETHYL-2H-PYRIDO[3,2-B][1,4]OXAZIN-3(4H)-ONE
- 71825-51-92-methyl-2-(4-nitrophenyl)propanenitrile
- Total:4 Page 1 of 1 1
What can I do for you?
Get Best Price
Chemistry
IUPAC Name: 5-[2-[4-(1,3-Benzodioxol-5-yl)butan-2-ylamino]-1-hydroxyethyl]-2-hydroxybenzamidehydrochloride
Following is the structure of Medroxalol hydrochloride (CAS NO.70161-10-3):
Empirical Formula: C20H25ClN2O5
Molecular Weight: 408.8759 g/mol
EINECS: 274-347-3
Flash Point: 319.1 °C
Enthalpy of Vaporization: 94.47 kJ/mol
Boiling Point: 604.1 °C at 760 mmHg
Vapour Pressure of Medroxalol hydrochloride (CAS NO.70161-10-3): 1.92E-15 mmHg at 25 °C
Canonical SMILES: CC(CCC1=CC2=C(C=C1)OCO2)NCC(C3=CC(=C(C=C3)O)C(=O)N)O.Cl
InChI: InChI=1S/C20H24N2O5.ClH/c1-12(2-3-13-4-7-18-19(8-13)27-11-26-18)22-10-17(24)14-5-6-16(23)15(9-14)20(21)25;/h4-9,12,17,22-24H,2-3,10-11H2,1H3,(H2,21,25);1H
InChIKey: YYWISFWLJSVFOF-UHFFFAOYSA-N
Safety Profile
Questionable carcinogen with experimental neoplastigenic data reported. When heated to decomposition, Medroxalol hydrochloride (CAS NO.70161-10-3) emits toxic vapors of NOx and HCl.
Specification
Medroxalol hydrochloride , its cas register number is 70161-10-3. It also can be called 5-(1-Hydroxy-2-((1-methyl-3-(3,4-(methylenedioxy)phenyl)propyl)amino)ethyl)salicylamide monohydrochloride ; 5-(2-((3-(1,3-Benzodioxol-5-yl)-1-methylpropyl)amino)-1-hydroxyethyl)-2-hydroxybenzamide HCl ; Medroxalol HCl ; and Benzamide, 5-(2-((3-(1,3-benzodioxol-5-yl)-1-methylpropyl)amino)-1-hydroxyethyl)-2-hydroxy-, monohydrochloride . Its classification code are Antihypertensive; Drug / Therapeutic Agent and Tumor data. Medroxalol hydrochloride (CAS NO.70161-10-3) is an antihypertensive agent with beta 1 adrenergic cardiac blocking properties, and beta 2 and some alpha 1 vasodilating activity.